These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 20068070

  • 1. FOXM1 confers acquired cisplatin resistance in breast cancer cells.
    Kwok JM, Peck B, Monteiro LJ, Schwenen HD, Millour J, Coombes RC, Myatt SS, Lam EW.
    Mol Cancer Res; 2010 Jan; 8(1):24-34. PubMed ID: 20068070
    [Abstract] [Full Text] [Related]

  • 2. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
    Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW.
    Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
    [Abstract] [Full Text] [Related]

  • 3. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.
    McGovern UB, Francis RE, Peck B, Guest SK, Wang J, Myatt SS, Krol J, Kwok JM, Polychronis A, Coombes RC, Lam EW.
    Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance.
    Khongkow P, Karunarathna U, Khongkow M, Gong C, Gomes AR, Yagüe E, Monteiro LJ, Kongsema M, Zona S, Man EP, Tsang JW, Coombes RC, Wu KJ, Khoo US, Medema RH, Freire R, Lam EW.
    Oncogene; 2014 Aug 07; 33(32):4144-55. PubMed ID: 24141789
    [Abstract] [Full Text] [Related]

  • 6. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
    Millour J, de Olano N, Horimoto Y, Monteiro LJ, Langer JK, Aligue R, Hajji N, Lam EW.
    Mol Cancer Ther; 2011 Jun 07; 10(6):1046-58. PubMed ID: 21518729
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.
    Kongsema M, Wongkhieo S, Khongkow M, Lam EW, Boonnoy P, Vongsangnak W, Wong-Ekkabut J.
    Oncol Rep; 2019 Sep 07; 42(3):953-962. PubMed ID: 31322278
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes.
    Tan Y, Raychaudhuri P, Costa RH.
    Mol Cell Biol; 2007 Feb 07; 27(3):1007-16. PubMed ID: 17101782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.
    Khongkow P, Gomes AR, Gong C, Man EP, Tsang JW, Zhao F, Monteiro LJ, Coombes RC, Medema RH, Khoo US, Lam EW.
    Oncogene; 2016 Feb 25; 35(8):990-1002. PubMed ID: 25961928
    [Abstract] [Full Text] [Related]

  • 14. FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.
    Nestal de Moraes G, Delbue D, Silva KL, Robaina MC, Khongkow P, Gomes AR, Zona S, Crocamo S, Mencalha AL, Magalhães LM, Lam EW, Maia RC.
    Cell Signal; 2015 Dec 25; 27(12):2496-505. PubMed ID: 26404623
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Knockdown of the FoxM1 enhances the sensitivity of gastric cancer cells to cisplatin by targeting Mcl-1.
    Li X, Liang J, Liu YX, Wang Y, Yang XH, Bao-Hongluan, Zhang GL, Du J, Wu XH.
    Pharmazie; 2016 Jun 25; 71(6):345-8. PubMed ID: 27455555
    [Abstract] [Full Text] [Related]

  • 17. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT, Huang YF, Tsai HY, Chen CC, Chang CH, Huang SC, Hsu KF, Chou CY.
    Oncotarget; 2015 Feb 10; 6(4):2349-65. PubMed ID: 25537512
    [Abstract] [Full Text] [Related]

  • 18. FOXM1 modulates cisplatin sensitivity by regulating EXO1 in ovarian cancer.
    Zhou J, Wang Y, Wang Y, Yin X, He Y, Chen L, Wang W, Liu T, Di W.
    PLoS One; 2014 Feb 10; 9(5):e96989. PubMed ID: 24824601
    [Abstract] [Full Text] [Related]

  • 19. FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.
    Li X, Yao R, Yue L, Qiu W, Qi W, Liu S, Yao Y, Liang J.
    J Cell Mol Med; 2014 May 10; 18(5):811-23. PubMed ID: 24628949
    [Abstract] [Full Text] [Related]

  • 20. Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells.
    Zhang X, Cheng L, Minn K, Madan R, Godwin AK, Shridhar V, Chien J.
    Oncotarget; 2014 Nov 30; 5(22):11365-80. PubMed ID: 25426548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.